GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Share News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,375.00
Bid: 2,350.00
Ask: 2,400.00
Change: -20.00 (-0.83%)
Spread: 50.00 (2.128%)
Open: 2,400.00
High: 2,380.00
Low: 2,380.00
Prev. Close: 2,400.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Craneware making 'positive progress' with Sentry integration

Tue, 16th Nov 2021 10:49

(Sharecast News) - Healthcare software company Craneware said in a trading update on Tuesday that it was making "positive progress" during the first four months of its new financial year, trading in line with its own expectations.
The AIM-traded firm, which was holding its annual general meeting, said the integration of Sentry Data Systems was progressing ahead of plan, with the integration of operational departments and operating systems nearing completion, and the sales and technology teams on track to be fully integrated by the end of the current financial year.

It said "good levels" of initial synergies had already been realised, more than mitigating the salary inflation being seen across the industry.

"Morale in the enlarged group is strong, with a collective passion to 'transform the business of healthcare' resulting in a lower attrition rate than the industry average widely reported," the Craneware board said in its statement.

Sales activity, meanwhile, was described by the company as high, with initial cross-sale opportunities emerging as expected across the two customer sets, alongside new customer opportunities.

The board said the migration of existing customers to the Trisus platform was continuing to plan, with all customers expected to be migrated by the end of the 2022 calendar year.

"The acquisition of Sentry has significantly increased Craneware's scale and opportunity, expanding the group's pharmacy offerings, customer base and valuable data sets, as well as increasing total revenue visibility for the next three years to approximately half a billion dollars," the directors said.

Craneware's artificial intelligence (AI) and data science team continue to analyse what the company believes to be the largest and most relevant independent proprietary hospital data set in the world.

"The group's aim is to identify future product opportunities further underpinning the long-term success of the company - achieving its mission: to profoundly impact healthcare by improving customers' operational efficiency and margins, so they can continue to invest in providing quality care for their communities."

Looking ahead, Craneware said that with a "strong" balance sheet, "high levels" of visible revenue and "strong" customer retention rates, it had a solid financial foundation from which to accelerate growth, increasing shareholder value.

"The board is confident in the continued strong performance of the business."

At 1029 GMT, shares in Craneware were up 1.15% at 2,630p.
More News
9 Nov 2021 14:49

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
5 Nov 2021 09:50

LONDON BROKER RATINGS: StanChart and Flutter upped to Buy; THG cut

LONDON BROKER RATINGS: StanChart and Flutter upped to Buy; THG cut

Read more
21 Sep 2021 12:33

IN BRIEF: Craneware lifts final payout; revenue rise offset by costs

IN BRIEF: Craneware lifts final payout; revenue rise offset by costs

Read more
21 Sep 2021 11:25

Craneware performs well as it completes Sentry acquisition

(Sharecast News) - United States healthcare software company Craneware reported a 6% improvement in revenue in its final results on Tuesday, to $75.6m.

Read more
21 Sep 2021 10:21

Berenberg raises target price on Craneware following 'positive' FY results

(Sharecast News) - Analysts at Berenberg hiked their target price on software outfit Craneware from 2,420.0p to 2,750.0p on Tuesday following the group's "positive" full-year results.

Read more
14 Sep 2021 16:11

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
13 Jul 2021 18:20

IN BRIEF: Craneware expects higher annual revenue; seals Sentry deal

IN BRIEF: Craneware expects higher annual revenue; seals Sentry deal

Read more
13 Jul 2021 10:00

Craneware sees positive sales momentum continue throughout H1

(Sharecast News) - Software outfit Craneware said on Tuesday that positive sales momentum experienced in the first half of the year had continued into the second half, with the group now expecting new sales to have increased approximately 40% to more than $42.0m.

Read more
8 Jun 2021 10:59

Craneware shares tank following share placing to fund Sentry purchase

Craneware shares tank following share placing to fund Sentry purchase

Read more
8 Jun 2021 10:55

AIM WINNERS & LOSERS: Kodal Minerals progresses licence in Mali

AIM WINNERS & LOSERS: Kodal Minerals progresses licence in Mali

Read more
7 Jun 2021 18:08

Craneware proposes placing to fund Sentry acquisition

Craneware proposes placing to fund Sentry acquisition

Read more
8 Apr 2021 16:05

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
11 Mar 2021 16:10

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
1 Mar 2021 11:22

TRADING UPDATES: CentralNic revenue doubles; Augean swing to profit

TRADING UPDATES: CentralNic revenue doubles; Augean swing to profit

Read more
1 Mar 2021 11:15

Revenue and earnings rise in first half at Craneware

(Sharecast News) - US-focussed healthcare software company Craneware reported a 6% improvement in its revenue for the first half on Monday, to $38m (£27.21m).

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.